Booth Bruce
SEC CIK 1451612 · EDGAR
BoughtSold
Most active insiders at KYMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Booth Bruce | Dir | — | $226.03M |
| 2 | BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | — | $173.67M |
| 3 | BAKER FELIX | Dir, 10% | $172.50M | — |
| 4 | Mainolfi Nello | CEO, Dir | — | $33.41M |
| 5 | Chadwick Jeremy G | COO | — | $15.60M |
| 6 | Jacobs Bruce N. | CFO | — | $9.96M |
| 7 | Gollob Jared | Chief Medical Off | — | $9.13M |
| 8 | Esposito Pamela | Dir | — | $3.05M |
| 9 | Goodman Noah | Chief Business Off | — | $2.22M |
| 10 | Ridloff Elena | Dir | — | $1.29M |
Transactions 33
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MATI | 2026-07-02 17:39 | 2026-06-29 | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $108.05 | -76.7K | 462.9K | -14% | -$8.28M |
| MTI | 2026-06-30 17:32 | 2026-06-29 | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $109.48 | -31.3K | 461.8K | -6% | -$3.42M |
| MTI | 2026-06-30 17:30 | 2026-06-26+ | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $110.01 | -513.2K | 466.1K | -52% | -$56.46M |
| MTI | 2026-06-25 21:56 | 2026-06-25 | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $121.86 | -285.7K | 529.7K | -35% | -$34.81M |
| MTI | 2026-06-25 21:55 | 2026-06-23+ | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $110.31 | -398.8K | 564.7K | -41% | -$43.99M |
| MTI | 2026-06-22 21:02 | 2026-06-22 | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $103.75 | -31.8K | 613.8K | -5% | -$3.30M |
| DT | 2026-06-22 21:01 | 2026-06-17 | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | M - OptEx | $20.00 | +11.7K | 11.7K | New | +$234.8K |
| DT | 2026-06-22 21:01 | 2026-06-17 | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale+OE | $89.98 | -11.7K | 0 | -100% | -$1.06M |
| DMTI | 2026-06-22 21:01 | 2026-06-17+ | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale+OE | $94.84 | -466.5K | 617.7K | -43% | -$44.24M |
| DMT | 2026-04-24 16:33 | 2026-04-22 | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | M - OptEx | $14.44 | +5,900 | 5,900 | New | +$85.2K |
| DT | 2026-04-24 16:33 | 2026-04-22 | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale+OE | $89.96 | -5,900 | 0 | -100% | -$530.8K |
| DMTI | 2026-04-24 16:33 | 2026-04-22 | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale+OE | $90.08 | -100 | 674.9K | -0.0% | -$9,008 |
| DMT | 2026-04-16 18:16 | 2026-04-14+ | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | M - OptEx | $14.18 | +6,359 | 2,200 | New | +$90.2K |
| DMT | 2026-04-16 18:16 | 2026-04-14+ | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale+OE | $89.96 | -6,359 | 0 | -100% | -$572.1K |
| DMTI | 2026-04-16 18:16 | 2026-04-15 | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale+OE | $90.10 | -3,135 | 675.0K | -0.5% | -$282.5K |
| MI | 2026-03-04 | 2026-03-02 | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $90.13 | -81.9K | 3.90M | -2% | -$7.38M |
| MI | 2025-12-12 | 2025-12-10+ | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $91.72 | -236.6K | 4.11M | -5% | -$21.70M |
| MI | 2025-10-21 | 2025-10-21 | SION | Sionna Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $34.22 | -88.9K | 2.36M | -4% | -$3.04M |
| MI | 2025-10-20 | 2025-10-16+ | SION | Sionna Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $32.30 | -286.4K | 2.48M | -10% | -$9.25M |
| MI | 2025-10-15 | 2025-10-10+ | SION | Sionna Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $30.47 | -194.9K | 771.8K | -20% | -$5.94M |
| MI | 2025-10-07 | 2025-10-03+ | SION | Sionna Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $29.99 | -49.5K | 787.5K | -6% | -$1.49M |
| MI | 2025-10-01 | 2025-09-29+ | SION | Sionna Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $30.08 | -78.7K | 2.83M | -3% | -$2.37M |
| DI | 2025-02-10 | 2025-02-10 | SION | Sionna Therapeutics, Inc. | Booth Bruce | Dir | P - Purchase | $18.00 | +60.0K | 807.7K | +8% | +$1.08M |
| DMI | 2025-02-10 | 2025-02-10 | SION | Sionna Therapeutics, Inc. | Booth Bruce | Dir | C - Cnv Deriv | — | +3.63M | 2.89M | New | — |
| MI | 2024-07-09 | 2024-07-09 | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $38.21 | -454.0K | 4.52M | -9% | -$17.35M |
| MI | 2024-06-14 | 2024-06-12+ | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $35.27 | -26.9K | 4.56M | -0.6% | -$950.2K |
| MI | 2024-03-15 | 2024-03-14+ | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $40.25 | -127.5K | 819.2K | -13% | -$5.13M |
| MI | 2024-03-13 | 2024-03-11+ | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $42.20 | -353.4K | 4.93M | -7% | -$14.91M |
| MI | 2023-01-13 | 2023-01-11+ | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $30.22 | -126.5K | 4.97M | -2% | -$3.82M |
| MI | 2022-12-16 | 2022-12-14+ | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $31.36 | -382.2K | 926.2K | -29% | -$11.99M |
| MI | 2022-11-04 | 2022-11-02+ | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $30.01 | -220.0K | 1.00M | -18% | -$6.60M |
| MI | 2022-11-01 | 2022-10-28+ | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $30.26 | -288.7K | 5.54M | -5% | -$8.74M |
| I | 2021-08-12 | 2021-08-11 | KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $61.00 | -242.1K | 0 | -100% | -$14.77M |
Purchase Sale Sale after option exercise All abbreviations